Hims & Hers rises as Lilly expands weight-loss drug access through platform
LLY•Hims & Hers shares rose 7.6% premarket after a new agreement made Eli Lilly’s Zepbound and Foundayo available through its platform. Zepbound will start at $299 per month and Foundayo at $149 per month.
1. Drugs available through platform
Eligible patients prescribed Zepbound or Foundayo by providers on Hims & Hers’ platform can access Lilly’s self-pay prices without leaving the platform. Patients can complete consultations, receive prescriptions if appropriate, and have the FDA-approved medicines shipped to their homes.
